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Objective: To examine the risk of large joint osteoarthritis (OA) in those becoming overweight during
early adult life, and to assess the risks associated with high body mass index (BMI) and other anthro-
pometric measures of obesity.
Methods: BMI, waist and hip circumference were measured in the GOAL case-control study comprising
hip OA cases (n¼ 1007), knee OA cases (n¼ 1042) and asymptomatic controls (n¼ 1121). Retrospective
estimates of lifetime weight, body shape and other risk factors were collected using an interview-lead
questionnaire. Odds ratios (ORs), adjusted OR (aOR), 95% conﬁdence intervals (CIs) and P values were
calculated using logistic regression analysis.
Results: BMI was associated with knee OA (aOR 2.68, 95% CI 2.33e3.09, P-trend< 0.001) and hip OA (aOR
1.65, 95% CI 1.46e1.87, P-trend< 0.001). Those who became overweight earlier in adulthood showed
higher risks of lower limb OA (P-trend< 0.001 for knee OA and hip OA). Self-reported body shape was also
associated with knee OA and hip OA, following a similar pattern to current and life-course BMI measures.
Waist:hip ratio (WHR) at time of examination did not associate with OA independently of BMI, except in
women-only analysis. Waist circumference was associated with lower limb OA risk.
Conclusions: Becoming overweight earlier in adult life increased the risks of knee OA and hip OA.
Different distribution patterns of adiposity may be related to OA risk in women.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Body mass index (BMI) is an established risk factor for knee
osteoarthritis (OA). A recent systematic review found 36 studies on
BMI and all showed a positive risk for knee OA1. Many studies have
used the current BMI of their participants, but prospective studies
have shown that BMI at baseline remains a strong risk factor2e5,
and is considered an important contributor to the causes of knee
OA.Weight loss can help reduce the incidence of symptomatic knee
OA6 and its effect as a treatment of knee OA have been observed byI, body mass index; WHR,
rcumference; OR, odds ratio;
: D.F. McWilliams, Academic
al, Nottingham NG5 1PB, UK.
(D.F. McWilliams).
the Arthritis Research UK
s Research Society International. Prandomised controlled trials7. Many studies have investigated the
association between BMI and hip OA, but with conﬂicting results. A
systematic review and meta-analysis published in 2002 concluded
that moderate evidence existed to associate hip OA with obesity,
with an odds ratio (OR) of approximately 28. However, many
studies also report no association between BMI and hip OA2,9.
Themechanism of the association between BMI and knee and hip
OA traditionally was thought to be purely biomechanical, with the
excess weight inducing deleterious effects on the joints. This makes
the differing associations between knee and hip OA with BMI
surprising because the forces from body weight pass through the
hips as well as the knees, although the different morphology of the
joints might explain different abilities to withstand adverse
mechanical loading. However, recent advances in adipose biology
have suggested the possibility that other factorsmay affect the joints.
Patterns of distribution of adipose tissue within the body and asso-
ciations with metabolic syndrome are now known, and adipocyto-
kines are secreted by and related to adipose tissue. The
adipocytokine, leptin is related to metabolic syndrome but also has
direct effects on chondrocytes10. Associations between hand OA andublished by Elsevier Ltd. All rights reserved.
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a metabolic/hormonal contribution to OA causes, rather than
a simple biomechanical mechanism. Evidence of such a factor is
currently weak with associations between metabolic correlates,
percentage fat and body fat distribution being non-signiﬁcant after
adjusting for BMI12e16. The Chingford study, a cohort comprised only
of women, identiﬁed an association between metabolic factors
(hypertension, hypercholesterolemia and blood glucose) and knee
OA that was independent of obesity17.
Studies on the distribution of adipose tissue use waist:hip ratio
(WHR) which is considered a surrogate marker of the central
obesity useful for determination of cardiovascular risks18, but its
value for OA research is unknown. Similarly, evidence on other
obesity measures such as waist circumference (WC), hip circum-
ference (HC), body shape and risk of knee and hip OA is sparse4.
The aim of the current study was to assess the risk of obesity,
using BMI and other related anthropometric measures, on severe
knee and hip OA in the large case-control study “Genetics of
Osteoarthritis and Lifestyle” (GOAL).
Methods
Study population
GOAL is a case-control study including hospital-referred hip OA
cases, knee OA cases and controls, designed to investigate genetic
and environmental risk factors19e22. All participants were unrelated
Caucasians living within the Nottingham area. Cases were recruited
from joint surgery lists from three Nottingham hospitals or from
a large joint OA clinic and all had been referred with clinically severe
OA for consideration of joint replacement surgery. Controls were
recruited from intravenous urography (IVU) waiting lists at the same
three hospitals and had experienced no knee or hip symptoms. For
this study, the group sizes were knee OA, n¼ 1042; hip OA, n¼ 1007;
controls, n¼ 1121. All participants were recruited with informed
consent. Ethical approval was granted by the Nottingham City
Hospital Local Research Ethics Committee (reference EC02/06).
Data collection
Data was collected in two stages; an interviewer-administered
lifestyle questionnaire and a clinical examination. During the clinical
examination weight (kg), height (cm), maximum WC (cm) at the
natural waist or umbilicus and pelvic bone HC (cm) were measured
by a trained research nurse. During the interviewer-administered
questionnaire individuals estimated their weight and their body
shape from a diagram (Fig. 1) at each decade of life23. Subjects were
asked if they had been diagnosed with hypertension, stroke, heart
disease; type I or type II diabetes; kidney problems, cancer,
depression or thyroid diseases by their doctor. Participants were
classiﬁed as having “metabolic disease” if they reported heart
problems, type II diabetes, stroke or hypertension. Self-reported
physical activities throughout life, smoking history and female
reproductive history were also recorded.
Measurement of obesity-related variables
BMI was calculated in kg/m2 and subjects were categorised into
three groups according to WHO criteria, speciﬁcally normal
(<25 kg/m2), overweight (25 and <30 kg/m2) and obese (30 kg/
m2). Prior to analysis, self-reported body shapes 6e7 and 8e9 were
taken to represent approximately the WHO BMI classes of “over-
weight” and “obese” respectively. Individuals retrospective esti-
mates of weight and current height were used to estimate mean
BMI at three stages; 20e30’s, 40e50’s and at their current age.
Subjects were then categorised into four groups of increasingexposure to BMI throughout life. The groups were: (1) BMI <25
throughout life, (2) BMI 25 only at recruitment, (3) BMI 25 from
middle age (40e50’s) onwards and (4) BMI 25 from 20’s to 30’s
onwards. Similar groups were derived for self-reported overweight
body shape (i.e., scale> 5) throughout life (Fig. 1). Control data-
derived tertiles were generated to categorise subjects for WC, HC
and WHR (calculated as WC/HC).
Other variables
Major risk factors for OA were included for the adjustment
purposes including age, gender, occupational risk, physical activity,
smoking, female reproductive history and oestrogen exposure.
Longest-held occupation was classiﬁed as manual or non-manual24
(which was used as a surrogate for social class), and also used to
estimate occupation risks. Heavy work standing (1 h per day), lift-
ing 25 kg (10 times perweek) or lifting 50 kgor 100 kg (1 timeper
week) were score for hip OA (maximum score 3). Kneeling or
squatting (1 h per day) were added for knee OA (maximum score
5)22. Physical activity was measured in hours per week between the
ages of 10 and 50, which was categorised into groups based upon
tertiles of the control population. Smoking was categorised as never,
current and ex-smoker. Exposure to oestrogen was determined as
low,moderate or high derived fromyears ofmenstruation, number of
pregnancies, years of HRTand contraceptive pill use; andwas used in
female-only analyses. Occupational exposures and female reproduc-
tive history were truncated to the age when ﬁrst joint replacement
took place. In average, cases were truncated 3 years earlier before the
recruitment date. This was therefore used to truncate all controls.
Representativeness of GOAL
The GOAL study control group was compared to other large UK
studies to assess how representative the sample group was. The
other studies were Norfolk EPIC25, the Hertfordshire cohort study
(HFCS)26, Prostate27, British National Survey28, British Regional
Heart Survey29 and Health Survey of England 199630.
Statistical analysis
ORs and 95% conﬁdence intervals (CIs) were calculated to present
the relative risk of exposure. Confounding factors were adjusted for
using logistic regression to generate adjusted OR (aOR). Logistic
regression was performed using the variables BMI/anthropometric
measures, age, gender, physical activity, metabolic disease co-
morbidity, oestrogen exposure (women only), social class, smoking
and occupational risks. When men and women were analysed
separately, only gender and oestrogen exposure were omitted from
the models. Doseeresponse relationships were examined whenever
the data were available for graded measures and P values for linear
trend are calculated. The differences in co-morbidities were assessed
using the c2 statistic. Correlations between obesity measures were
assessed by Pearson’s coefﬁcient. Anthropometricmeasures and BMI
were included together in logistic regression models to estimate
whether both independently conferred risks forOA.All analyseswere
performed using SPSS version 14. Statistical signiﬁcance was taken
when P< 0.05.
Results
The demographics of the GOAL study are shown in Table I. The
control group had lower BMI, WC, HC, and WHR and was younger
than the knee OA and hip OA groups, but contained more current
smokers. The control group also had fewer subjects with self-
reported metabolic diseases but more subjects with depression,
kidney diseases and cancer.
Table I
Demographics of GOAL study
Controls Hip OA Knee OA
N¼ 1121 1007 1042
Age (s.d.; yrs) 64.2 (8.4) 67.6 (7.1)** 68.1 (7.4)**
% Women 46.5% 50.5% 48.6%
BMI (s.d.; kg/m2) 27.5 (4.6) 29.3 (5.2)** 31.2 (5.4)**
WC (s.d.; cm) 95.5 (12.9) 99.5 (13.5)** 102.6 (12.7)**
HC (s.d.; cm) 106.1 (9.3) 109.5 (10.8)** 112.6 (11.2)**
WHR (s.d.) 0.898 (0.079) 0.908 (0.081)* 0.911 (0.081)**
Smoking
Never 36% 40% 44%
Ex- 44% 50% 46%
Current 20%** 10% 10%
Manual occupation 49% 54%* 61%**
Occupational Risks 38% 43%* 51%**
Metabolic diseases 48% 55%** 61%**
Depression 23% 17%** 19%*
Kidney problems 39% 6%** 6%**
Cancer 19% 9%** 8%**
The number per group, mean (s.d.) or percentage prevalence are presented.
**P< 0.01, *P< 0.05 vs controls.
Fig. 1. Body shape diagram. Line drawing for self-assessed body shape throughout life.
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decade of life (e.g., 20e30’s: r¼ 0.359, P< 0.001; 40e50’s:
r¼ 0.684, P< 0.001 and 60’s/current: r¼ 0.655, P< 0.001). WC and
HC were also correlated with BMI (r¼ 0.76 for WC and BMI and
r¼ 0.86 for HC and BMI).
BMI
The participants’ current BMI was associated signiﬁcantly with
knee OA (aOR 2.68, 95% CI 2.33e3.09, P-trend< 0.001) and hip
OA (aOR 1.65, 95% CI 1.46e1.87, P-trend< 0.001) (Fig. 2). A
doseeresponse relationship was found both in terms of current
BMI [Fig. 2(A and B)] and the duration of being overweight [Fig. 2(C
and D)].
The risk of knee OA associated with current BMI appeared to be
greater in women (aOR 3.23, 95% CI 2.62e3.98, P-trend< 0.001)
than men (aOR 2.20, 95% CI 1.81e2.66, P-trend< 0.001). The risks
for hip OA were, however, broadly similar between genders
(women aOR 1.69, 95% CI 1.41e2.04, P-trend< 0.001; and men aOR
1.51, 95% CI 1.26e1.80, P-trend< 0.001).
The participants’ life-course BMI was signiﬁcantly associated
with knee OA (aOR 1.89, 95% CI 1.71e2.09, P-trend< 0.001) and hip
A B
C D
Fig. 2. BMI and risks of OA. Participants’ current and self-assessed life-course BMIs were stratiﬁed and used to calculate aOR (95% CI). Current BMI and risks of (A) knee OA and
(B) hip OA. Self-reported overweight (25) throughout life and risks of (C) knee OA and (D) hip OA. The results are adjusted for age, gender, social class, occupation, physical activity,
metabolic diseases and smoking.
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increases in BMI conferring greater risk [Fig. 2(C and D)]. The risks of
knee OA appeared greater in women (aOR 2.33, 95% CI 1.98-2.75,
P-trend< 0.001) than in men (aOR 1.55, 95% CI 1.36e1.77,
P-trend< 0.001). The risks of hip OA were similar between genders
(women aOR 1.46, 95% 1.29e1.65, P-trend< 0.001; and men aOR
1.39, 95% CI 1.21e1.59, P-trend< 0.001).
Body shape
Similar doseeresponse association was observed with the self-
reported body shapes (Fig. 3). The risks of knee OA associated with
shape in age 60’s appeared stronger in women (aOR 2.67, 95% CI
2.12e3.34, P-trend< 0.001) than inmen (aOR 1.36, 95% CI 1.56e2.38,
P-trend< 0.001). The risks of hip OA were similar between women
(aOR 1.60, 95% CI 1.30e1.97, P-trend< 0.001) andmen (aOR 1.43, 95%
CI 1.17e1.75, P-trend¼ 0.001).
The risks of knee OA associated with large body shape through
life were also greater in women (aOR 1.98, 95% CI 1.65e2.37,
P-trend< 0.001) than in men (aOR 1.53, 95% CI 1.31e1.79,
P-trend< 0.001). The risks of hip OA were similar between women
(aOR 1.49, 95% CI 1.26e1.75, P-trend< 0.001) and men (aOR 1.37,
95% CI 1.18e1.58, P-trend< 0.001).
The impact of body fat distribution on OA risk
Although greater WC and HC were associated with risk for knee
OA and hip OA, the association was weaker than that with BMI
(Table II). After adjustment for BMI and other confounders, no
increased risks for OAwere found fromWHR or HC. Inwomen-only
analysis, the risk for hip OA was associated with WHR (aOR 1.31,
95% CI 1.06e1.62, P-trend¼ 0.013), but not the risk for knee OA
(aOR 1.05, 95% CI 0.84e1.33, P-trend¼ 0.666), and neither wasrelated to OA in men. Smaller risks than those from BMI were
observed fromWC in knee OA and also hip OA (Table II). Inwomen-
only analysis the risk of knee OAwas associatedwith increasingWC
(aOR 1.53, 95% CI 1.20-1.96, P-trend¼ 0.001) as was the risk of hip
OA (aOR 1.49, 95% CI 1.18-1.89, P-trend¼ 0.001), where in men the
adjusted risks were close to unity.
Co-morbidities
Self-reported co-morbidities were used to classify participants
as having a metabolic disease. Metabolic disease was associated
with increasing BMI (P< 0.001) and WHR (P< 0.001) as well as
knee OA (P< 0.001). The control group had higher prevalence of
cancer, depression and kidney problems (Table I).
Representativeness of GOAL
The control group of GOAL was compared to other large UK
studies, to assess how representative GOAL was. Major demo-
graphics are summarised in Table III, and the GOAL control group
was broadly similar to these studies for age range, BMI and smoking
status.
Discussion
We have undertaken an epidemiological analysis of obesity-
related variables in a large case-control data set (GOAL) derived
from the Nottingham region. It was observed that being
overweight or obese was strongly associated with knee OA and
hip OA. A trend for greater risk for knee and hip OA with
increasing duration of being overweight was also found. Women
consistently showed more risk for knee OA from obesity than
men. The WHR was only related independently to the risk in hip
ADC
B
Fig. 3. Self-assessed body shape and risks of OA. Participants’ self-assessed body shape on an ascending scale (0e9) was stratiﬁed and used to calculate aOR (95% CI). Current body
shape and risks of (A) knee OA and (B) hip OA. Self-reported large body shape (>5) throughout life and risks of (C) knee OA and (D) hip OA. The results are adjusted for age, gender,
social class, occupation, physical activity, metabolic diseases and smoking.
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disease.
The patterns of risk observed here are consistent with previous
studies showing BMI as an independent risk factor for knee OATable II
Risks of OA related to measures of obesity
Categories Controls Knee OA
N N Univariate Adjusted
BMI
1 347 99 1 1
2 488 375 2.70 (2.08e3.51)** 2.33 (1.7
3 286 567 6.94 (5.33e9.05)** 7.48 (5.4
P-trend< 0.001
WHR
1 373 308 1 1
2 375 327 1.06 (0.86e1.31) 0.89 (0.6
3 372 402 1.31 (1.07e1.61)* 1.18 (0.7
P-trend¼ 0.862
WC
1 374 144 1 1
2 370 323 2.27 (1.78e2.89)** 1.44 (1.0
3 377 575 3.96 (3.14e5.00)** 1.59 (1.0
P-trend¼ 0.007
HC
1 370 142 1 1
2 365 283 2.02 (1.58e2.59)** 1.18 (0.8
3 386 617 4.17 (3.30e5.25)** 1.26 (0.8
P-trend¼ 0.134
The risks for lower limb OA conferred bymeasures of obesity are presented, to investigate
presented using the lowest category of BMI, WHR, WC and HC as reference. OR (95% CI)
**P< 0.01, *P< 0.05.
y Adjusted for age, gender, social class, occupation risks, physical activity, smoking, m(reviewed in Ref.1). Previous studies estimating risk for hip OA
either found no association or else reported smaller risks than in
knee OA. Here we also observed smaller estimates for hip OA risk
when compared to knee OA. Our ﬁndings also support theHip OA
y N Univariate Adjustedy
194 1 1
5e3.10)** 419 1.57 (1.26e1.95)** 1.51 (1.19e1.92)**
5e10.27)** 394 2.49 (1.97e3.14)** 2.54 (1.93e3.35)**
P-trend< 0.001
303 1 1
6e1.21) 332 1.09 (0.88e1.35) 1.08 (0.82e1.43)
6e1.83) 371 1.23 (1.00e1.51) 1.40 (0.95e2.05)
P-trend¼ 0.106
230 1 1
3e1.99)* 325 1.43 (1.14e1.78)** 1.38 (1.02e1.85)*
5e2.39)* 452 1.95 (1.57e2.41)** 1.45 (0.98e2.13)
P-trend¼ 0.013
216 1 1
7e1.61) 318 1.49 (1.19e1.87)** 1.16 (0.89e1.53)
6e1.85) 473 2.10 (1.69e2.60)** 1.06 (0.74e1.51)
P-trend¼ 0.346
whether anymeasures are independent risk factors. Risks for knee OA and hip OA are
and aOR (95% CI) are presented.
etabolic diseases and BMI (or WHR when BMI is dependent variable).
Table III



















Mean BMI 27.7 27 N/C N/C 26.8 26.7
Never smoked % 27 18 31 25 32 N/C
Ex-smoker % 54 60 49 58 51 N/C




65e74 55e64 N/C 65.5 65e74
Mean BMI 27.3 27.3 N/C N/C 26.7 26.6
Never smoked % 45 36 52 N/C 60 N/C
Ex-smoker % 32 40 27 N/C 29 N/C
Current smoker % 27 24 21 N/C 11 N/C
A comparison of demographics between GOAL and other large UK studies.
HSE e Health Survey of England; N/C e not compared to GOAL.
K.L. Holliday et al. / Osteoarthritis and Cartilage 19 (2011) 37e4342prospective studies where increasing BMI earlier in life was a risk
factor for knee OA31,32. Also, our ﬁndings support those from
Lohmander et al. where WHR and other measures of obesity were
poorly associated with OA once BMI had been accounted for4.
Gender differences in the risk for knee OA conferred by BMI were
evident in our study, and have been reported by other groups33. Hip
OA risks conferred by BMI and body shape did not appear to vary
between genders. Our estimate of oestrogen exposure did not
greatly alter the risks, although it was compiled from self-reported
medical histories which will lack some degree of accuracy.
The literature mostly suggests that body fat distribution is not
associated with OA14e16,34, independently of BMI, as with our global
observations of WHR. Numerically, WHR did not vary greatly
between cases and controls, despite the differences achieving
statistical signiﬁcance. However, in women-only analyses, associa-
tions were found between WHR and OA, which may indicate
a gender difference in obesity-related risk. Some recent studies have
observed a BMI-independent association between knee OA and
WC4,35, whichwe also report here andwhich appears to be restricted
to the female cases. Patients with OA displayed increased prevalence
of metabolic diseases, although these were self-reported during the
interview. In other studies, patients with knee OA were more likely
to have metabolic syndrome, although the association may not be
independent of confounders36. The Chingford study, however,
identiﬁed an association between metabolic factors (hypertension,
hypercholesterolemia, and blood glucose) and knee OA in women
that was independent of obesity17. The metabolic and endocrine
actions of adipose tissue, such as leptin production, may contribute
to OA, possibly to a greater extent in women. However, little is
known at present about any potential mechanisms. In addition to
metabolic diseases, the GOAL control group also had higher preva-
lence of depression, cancer and kidney problems, which is likely to
be due to their recruitment from hospital IVU lists.
The GOAL case-control study was designed for the purpose of OA
risk factor characterisation and is sufﬁciently powered to investigate
association with genes and lifestyle/clinical risk factors19e22. The
GOAL study group appears to be representative of other large UK
studies. The BMI of the GOAL control group was comparable to that
of other control groups in a number of UK case-control and cohort
studies suggesting that there were not substantial biases during
selection. GOAL is also a retrospective study with most of the cases
having already undergone joint replacements, therefore, measures
of BMI, WC and HC are subsequent to disease. The data used for the
analysis of life-course BMI are estimates of weight within eachdecade of life, which may be subject to recall bias and error, and the
BMI was calculated using height, as measured in the study, which
means that some calculated BMIs will be overestimates due to
subjects losing height with age. However, this effect is probably
minimal and will occur across the whole data set. All measures of
obesity were classiﬁed into three groups, minimising the effects of
small inaccuracies on the analyses. Another limitation in this analysis
is the ability to accurately measure WC and HC. It is particularly
difﬁcult to determine HC in larger individuals. It also gives no indi-
cation to the type of fat, subcutaneous or visceral.
In conclusion obesity, as measured by BMI, is a major risk factor
for OA, with the extent of the risk differing due to the affected joint,
duration of exposure and possibly gender. Here WHR was not an
independent risk factor for lower limb OA, after accounting for BMI.Contributions
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